financetom
Business
financetom
/
Business
/
Will cross new orders guidance of Rs 10,000 crore in FY21: NCC
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Will cross new orders guidance of Rs 10,000 crore in FY21: NCC
Oct 2, 2020 11:00 AM

NCC (formerly Nagarjuna Construction Company) expects to cross its guidance of fresh orders worth Rs 10,000 crore for this fiscal, the company's Executive Vice President, Finance, YD Murthy told CNBCTV18 in an interview.

Murthy said the company had bagged Rs 5500 crore of orders in the first half of this year and expected order flows to pick up in the next couple of quarters.

He said the company already had Letters of Intent from clients and expected firm commitments from them starting this month.

Murthy said execution of projects was at 65-70 percent of pre-COVID levels during the quarter ended September. He expected it to further rise to 90 percent in October.

Watch video for more.

First Published:Oct 2, 2020 8:00 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nasdaq sees bigger year ahead for listings on billion-dollar-plus IPOs
Nasdaq sees bigger year ahead for listings on billion-dollar-plus IPOs
Mar 10, 2026
NEW YORK, Dec 18 (Reuters) - Nasdaq expects a jump in initial public offerings next year driven by several large startups aiming to tap U.S. capital markets in coming months, a top company executive told Reuters.  The forecast suggests a potential rebound in market confidence for new flotations, a key indicator of economic health, as both companies and investors look...
BeOne Medicines Says US FDA's Fast Track Designation Received for Hepatocellular Carcinoma Treatment
BeOne Medicines Says US FDA's Fast Track Designation Received for Hepatocellular Carcinoma Treatment
Mar 10, 2026
06:57 AM EST, 12/18/2025 (MT Newswires) -- BeOne Medicines ( ONC ) said Thursday its BGB-B2033 antibody has received the US Food and Drug Administration's Fast Track Designation to treat adult patients with hepatocellular carcinoma. The company is currently carrying out a phase 1 clinical study to evaluate the safety and anti-tumor activity of BGB-B2033, BeOne Medicines ( ONC )...
Howard Hughes to Issue $1 Billion in Preferred Stock to Pershing Square in Connection With Vantage Acquisition
Howard Hughes to Issue $1 Billion in Preferred Stock to Pershing Square in Connection With Vantage Acquisition
Mar 10, 2026
06:55 AM EST, 12/18/2025 (MT Newswires) -- Howard Hughes (HHH) will issue up to $1 billion of non-voting exchangeable perpetual preferred stock to Pershing Square as part of its planned $2.1 billion acquisition of Vantage, Pershing Square said Thursday. The preferred stock will become exchangeable into Vantage common stock if not fully repurchased within 60 days after seven years following...
Howard Hughes to Acquire Vantage Group for About $2.1 Billion
Howard Hughes to Acquire Vantage Group for About $2.1 Billion
Mar 10, 2026
06:55 AM EST, 12/18/2025 (MT Newswires) -- Howard Hughes (HHH) said Thursday it has entered a definitive agreement to acquire privately held specialty insurance and reinsurance company Vantage Group, a specialty insurance and reinsurance company backed by Carlyle (CG), for about $2.1 billion. Under the agreement, Howard Hughes will fund the acquisition with about $1.2 billion cash and up to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved